G01N 2333/96466
Cysteine endopeptidases
Official title: Cysteine endopeptidases (3.4.22)
G01N2333/96466 (Cysteine endopeptidases) appears on 127 US grants and 208 published applications in this corpus.
Search patents in G01N- Granted patents
- 127
- Published applications
- 208
- Assignees
- 152
- Inventors
- 529
- Latest grant
- 2 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 7 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 1 |
| 2002 | 4 | 7 |
| 2003 | 3 | 9 |
| 2004 | 1 | 4 |
| 2005 | 2 | 6 |
| 2006 | 4 | 9 |
| 2007 | 3 | 11 |
| 2008 | 3 | 5 |
| 2009 | 5 | 8 |
| 2010 | 4 | 14 |
| 2011 | 3 | 13 |
| 2012 | 3 | 11 |
| 2013 | 6 | 7 |
| 2014 | 11 | 10 |
| 2015 | 10 | 14 |
| 2016 | 4 | 11 |
| 2017 | 6 | 8 |
| 2018 | 2 | 9 |
| 2019 | 6 | 7 |
| 2020 | 6 | 8 |
| 2021 | 3 | 3 |
| 2022 | 4 | 6 |
| 2023 | 4 | 10 |
| 2024 | 5 | 4 |
| 2025 | 2 | 7 |
| 2026 | 0 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods for measuring and inhibiting calpain-5 activity2 Dec 2025US 12,486,528 B2The Board of Trustees of the Leland Stanford Junior University
- Direct affinity measurement of human IgG1 binding multimeric antigens29 Apr 2025US 12,287,335 B2Hoffmann-La Roche Inc.
- Chemiluminescent probes for imaging/detection of proteases24 Dec 2024US 12,173,350 B2Ramot at Tel-Aviv University Ltd.
- Treatment with an IL-2 based therapy12 Nov 2024US 12,138,282 B2Aelan Cell Technologies, Inc.
- Method for determining the in vivo interaction mode16 Apr 2024US 11,958,912 B2Hoffmann-La Roche Inc.
- Peptide substrates and inhibitors of cathepsin b10 Sep 2026US 2026/0265298 A1The Regents of the University of California
- Malt1 tumor inhibitor, pharmaceutical composition containing the same, and applications thereof3 Sep 2026US 2026/0258425 A1Xzyp (Beijing) Biotech Co., Ltd
- Assay system for developing honeybee antiviral agent using inhibition of virus-derived protease as indicator20 Aug 2026US 2026/0242843 A1Toyama Prefectural University
- Diagnosis of skin conditions in veterinary and human patients30 Jul 2026US 2026/0218307 A1Trustees of Tufts College
- Biomarkers for Long COVID7 May 2026US 2026/0126444 A1Szegedi TudomáNyegyetem
Most cited
By later US patents
- Methods for determining the prognosis for cancer patients using tucan86US 7,163,801 B2The Burnham Institute · 2007
- ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting80US 5,340,736 APresident and Fellows of Harvard College · 1994
- Fluorogenic peptides for the detection of protease activity60US 6,037,137 AOncoimmunin, Inc. · 2000
- Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis58US 5,976,822 ACoulter International Corp. · 1999
- Method for determining activity of enzymes in metabolically active whole cells34US 5,698,411 ACoulter Corporation · 1997